Nomura Analyst Sees Fast Growth At BioMarin Pharmaceutical

By: via Benzinga
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) pipeline and existing products could drive a doubling of revenue every four years, an ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.